Sodium valproate in the treatment of levodopa-induced dyskinesia.
暂无分享,去创建一个
[1] K. E. Moore,et al. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function , 1976, Nature.
[2] C. Symons,et al. Measurement of A.D.P.-induced platelet aggregation and A.D.P.-splitting enzymes in plasma. , 1966, Lancet.
[3] I. Kennedy. Letter: The story of tuberculosis. , 1973, Lancet.
[4] P. Bédard,et al. CHOREA AND TORSION IN PARKINSONISM , 1976, The Lancet.
[5] T. Hökfelt,et al. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. , 1975, Medical biology.
[6] Glutamic-acid decarboxylase and choline acetylase in Huntington's chorea and Parkinson's disease. , 1973, Lancet.
[7] H. Fibiger,et al. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. , 1973, Brain research.
[8] E. Roberts. Gamma-aminobutyric acid and nervous system function--a perspective. , 1974, Biochemical pharmacology.
[9] J. E. Rees,et al. A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone. , 1973, Lancet.
[10] O. Hornykiewicz,et al. L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy , 1973, Nature.
[11] B. Meldrum,et al. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures. , 1976, Biochemical pharmacology.
[12] C. Marsden,et al. The behavioural effects of manipulating GABA function in the globus pallidus , 1976, Brain Research.
[13] M. Linnoila,et al. Effect of Sodium Valproate on Tardive Dyskinesia , 1976, British Journal of Psychiatry.
[14] C. Marsden,et al. Rotational behavior induced in rats by intranigral picrotoxin , 1975, Brain Research.